Merck & CO., INC. (MRK) — 8-K Filings

8-K Filings (14)

• Merck & Co. Files 8-K on Financial Instruments — Dec 4, 2025 Risk: low
  On December 4, 2025, Merck & Co., Inc. filed an 8-K report detailing various financial instruments, including common stock and several series of notes due betwe
• Merck & Co. Files 8-K on Financials — Oct 30, 2025 Risk: low
  Merck & Co., Inc. filed an 8-K on October 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and
• Merck & Co. Files 8-K on Financial Instruments — Sep 9, 2025 Risk: low
  On September 9, 2025, Merck & Co., Inc. filed an 8-K report detailing various financial instruments, including common stock and several series of notes with var
• Merck & Co. Files 8-K on Financials and Exit Costs — Jul 29, 2025 Risk: medium
  Merck & Co., Inc. filed an 8-K on July 29, 2025, reporting results of operations and financial condition as of July 25, 2025. The filing also details costs asso
• Merck & Co. Files 8-K on Security Holder Vote Matters — May 29, 2025 Risk: low
  On May 27, 2025, Merck & Co., Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not specify the na
• Merck & Co. Files 8-K on Financials — Apr 24, 2025 Risk: low
  Merck & Co., Inc. filed an 8-K on April 24, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and e
• Merck & Co. Files 8-K on Financials — Feb 4, 2025 Risk: low
  Merck & Co., Inc. filed an 8-K on February 4, 2025, to report on its results of operations and financial condition. The filing includes financial statements and
• Merck & Co. Files 8-K: Director Changes, Compensation, Bylaws — Nov 22, 2024 Risk: low
  On November 19, 2024, Merck & Co., Inc. filed an 8-K report detailing several key events. The company announced the election of new directors and changes in off
• Merck & Co. Files 8-K on Financials — Oct 31, 2024 Risk: low
  Merck & Co., Inc. filed an 8-K on October 31, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and
• Merck & Co. Files 8-K on Financials and Debt — Jul 30, 2024 Risk: low
  Merck & Co., Inc. filed an 8-K on July 30, 2024, to report on its results of operations and financial condition. The filing includes financial statements and ex
• Merck & Co. Files 8-K on Shareholder Votes and Notes — May 30, 2024 Risk: low
  On May 28, 2024, Merck & Co., Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and other events. The filing includes f
• Merck & Co. Files 8-K on Financial Condition — Apr 25, 2024 Risk: low
  Merck & Co., Inc. filed an 8-K on April 25, 2024, reporting on its results of operations and financial condition. The filing includes details about various debt
• Merck 8-K Signals Potential Leadership or Compensation Changes — Feb 20, 2024 Risk: medium
  Merck & Co., Inc. filed an 8-K on February 20, 2024, reporting an event that occurred on February 15, 2024. The filing pertains to "Departure of Directors or Ce
• Merck Files 8-K for Corporate Communications, Rule 425 & 14a-12 — Feb 1, 2024
  Merck & Co., Inc. filed an 8-K on February 1, 2024, reporting an event that occurred on January 29, 2024. This filing indicates that Merck is satisfying its fil

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX